Tesla (TSLA) Launches SixSeat Model Y L in US to Boost Sales

Tesla, Inc. (NASDAQ:TSLA) makes electric vehicles, batteries and energy storage systems, and it just rolled out a six seat, long wheelbase version of its Model Y SUV in the United States, a move meant to reignite demand after Washington pulled a major EV tax credit. Shares fell 7.49% on the news to 393.45 dollars.

• Model Y L launches in the US priced at 61,990 dollars, with 325 miles of range and a three row, six seat layout
• Tesla previously introduced the longer Model Y in China last year, where it helped offset pressure from BYD and other local rivals
• TSLA shares dropped 7.49% to 393.45 dollars, well inside a 52 week range of 364.02 to 453.40
• Market cap sits at 1.48 trillion dollars despite the pullback, with a P/E ratio of 327.88
• RSI reads 46.9, a neutral signal that suggests the stock is neither overbought nor oversold

In Brief

• Tesla launched the Model Y L, a stretched six seat variant of its top selling SUV, in the US on Thursday
• The vehicle costs 61,990 dollars and offers 325 miles of range on a single charge
• The move follows the expiration of a federal EV tax credit that had been cushioning US sales
• Tesla also reported record second quarter delivery figures that beat Wall Street forecasts, driven by a rebound in Europe

Why Tesla Needed This Launch

Rather than build an entirely new model, Tesla has leaned on variants of its existing Model Y and Model 3 lineup to keep buyers interested. The six seat Model Y L already proved itself in China last year, where it helped Tesla hold ground against BYD and a crowded field of domestic automakers, before spreading to other markets across the Asia Pacific region. Bringing that same formula to the US comes at a pointed moment: the removal of a federal tax credit last year had cooled American demand, and the extra row of seating gives Tesla a fresh pitch to families who might otherwise cross shop with three row gas SUVs.

The timing lines up with Tesla's second quarter delivery report, which came in ahead of Wall Street estimates and set a company record, largely thanks to stronger sales in Europe. That combination, a demand recovering region overseas and a new US variant aimed at a soft domestic market, is feeding hope that 2026 could be the year Tesla finally snaps its two year streak of annual sales declines.

Tesla Valuation, Momentum and Yield

Here is where the numbers get interesting. TSLA trades at 393.45 dollars after Thursday's 7.49% slide, still comfortably within its 52 week band of 364.02 to 453.40, so this isn't a stock breaking to new lows, just one absorbing a sharp single day reaction. The market cap of 1.48 trillion dollars keeps Tesla among the most valuable companies on the planet, and the P/E ratio of 327.88 reflects a valuation built almost entirely on future growth expectations rather than current earnings. Tesla does not currently pay a dividend, so income investors get nothing here beyond the possibility of share price appreciation.

The RSI of 46.9 sits right in neutral territory, meaning momentum traders aren't seeing a stock that's been beaten down into oversold conditions or stretched into overbought froth. The bull case rests on the idea that a cheaper, more spacious Model Y variant plus European strength could finally reverse two years of falling deliveries, giving some justification to that lofty multiple. The bear case is just as straightforward: a P/E above 300 leaves very little room for disappointment, and a stock that can fall 7.49% in a single session on what was, on its face, a product launch shows how sensitive sentiment remains around this name.

What Comes Next for Tesla's US Demand

Whether the Model Y L can actually replicate its Chinese success in the US market is the open question hanging over Tesla right now. The vehicle's extra range and third row give it a genuine selling point, but American buyers face a different competitive landscape and no longer get federal tax help to soften the 61,990 dollar price tag. If the record delivery quarter and this new variant combine to end the company's two year sales slide, that would mark a meaningful turning point for a stock whose valuation already assumes plenty of good news.